Vivimed Labs Stock Price Analysis and Quick Research Report. Is Vivimed Labs an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Vivimed Labs. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vivimed Labs has a PE ratio of -9.06426770258298 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vivimed Labs has ROA of -4.7692% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vivimed Labs has a Current ratio of 0.6302.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vivimed Labs has a ROE of -87.6118%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Vivimed Labs has a Debt to Equity ratio of 18.292 which means that the company has high proportion of debt in its capital.

• Sales growth: Vivimed Labs has reported revenue growth of -24.2644% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Vivimed Labs for the current financial year is -14.0071811899155%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vivimed Labs is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Vivimed Labs is Rs -2.9346. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Vivimed Labs in Ticker for free. Also, one can get the intrinsic value of Vivimed Labs by using Valuation Calculators, which are available with a Finology ONE subscription. 

Vivimed Labs FAQs

Q1. What is Vivimed Labs share price today?
Ans: The current share price of Vivimed Labs is Rs 26.6.

Q2. What is the market capitalisation of Vivimed Labs?
Ans: Vivimed Labs has a market capitalisation of Rs 220.5510139 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Vivimed Labs?
Ans: The PE ratio of Vivimed Labs is -9.06426770258298 and the P/B ratio of Vivimed Labs is 2.75927885313583, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Vivimed Labs share?
Ans: The 52-week high share price of Vivimed Labs is Rs 0, and the 52-week low share price of Vivimed Labs is Rs 0.

Q5. Does Vivimed Labs pay dividends?
Ans: Currently, Vivimed Labs does not pay dividends. Dividend yield of Vivimed Labs is around 0%.

Q6. What are the face value and book value of Vivimed Labs shares?
Ans: The face value of Vivimed Labs shares is Rs 2, while the book value per share of Vivimed Labs is around Rs 9.6402. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Vivimed Labs?
Ans: Vivimed Labs has a total debt of Rs 374.822 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Vivimed Labs?
Ans: The ROE of Vivimed Labs is -87.6118% and ROCE of Vivimed Labs is -7.0441%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Vivimed Labs a good buy for the long term?
Ans: The Vivimed Labs long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Vivimed Labs undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Vivimed Labs appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Vivimed Labs’s financials?
Ans: You can review Vivimed Labs’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.